Abstract

This contract supports the preclinical, nonclinical, and clinical development (phase I and phase II) of Fludase as a broad spectrum therapeutic agent for all annual and pandemic variations of influenza.

  Funding Agency

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research and Development Contracts (N01)
Project #
N01AI60015-5-0-1
Application #
8020431
Study Section
Project Start
2006-09-29
Project End
2011-09-28
Budget Start
Budget End
Support Year
Fiscal Year
2010
Total Cost
$9,999,165
Indirect Cost

  Institution

Name
Nexbio, Inc.
Department
Type
DUNS #
140600268
City
San Diego
State
CA
Country
United States
Zip Code
92121